E Fund Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$524K Buy
1,343
+180
+15% +$76.1K 0.01% 255
2026
Q1
$550K Buy
+1,163
New +$585K 0.02% 276
2025
Q2
$448K Sell
1,170
-223
-16% -$80.4K 0.02% 242
2025
Q1
$481K Sell
1,393
-99
-7% -$31.8K 0.02% 229
2024
Q4
$448K Buy
1,492
+753
+102% +$263K 0.02% 242
2024
Q3
$300K Sell
739
-72
-9% -$26.4K 0.02% 261
2024
Q2
$261K Sell
811
-42
-5% -$13.6K 0.01% 254
2024
Q1
$285K Buy
853
+9
+1% +$2.75K 0.02% 283
2023
Q4
$228K Buy
+844
New +$209K 0.01% 263
2023
Q3
Sell
-690
Closed -$209K 306
2023
Q2
$209K Sell
690
-96
-12% -$26.7K 0.02% 275
2023
Q1
$207K Sell
786
-76
-9% -$19.3K 0.02% 293
2022
Q4
$207K Buy
+862
New +$193K 0.02% 299
2022
Q2
Sell
-871
Closed -$218K 334
2022
Q1
$218K Sell
871
-164
-16% -$41.2K 0.01% 279
2021
Q4
$266K Sell
1,035
-10
-1% -$2.45K 0.01% 223
2021
Q3
$254K Buy
+1,045
New +$255K 0.01% 203

Other funds holding HCA

E Fund Management's HCA Position: Q2 2026 in Review

E Fund Management increased its HCA Healthcare (HCA) stake by 15% in Q2 2026, buying an estimated $76.1K and bringing the position to 1,343 shares worth $524K. The position accounts for 0.01% of the portfolio, ranked #255.

E Fund Management first reported a position in HCA in Q3 2021 and has held it in 15 quarters since. The position peaked at $550K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • E Fund Management held 1,343 shares of HCA Healthcare worth $524K as of Q2 2026.
  • E Fund Management bought 180 HCA Healthcare shares in Q2 2026, an estimated $76.1K.
  • HCA Healthcare made up 0.01% of E Fund Management's portfolio in Q2 2026, its #255 holding.
  • E Fund Management first reported a position in HCA Healthcare in Q3 2021 and has held it in 15 quarters since.
  • E Fund Management's HCA Healthcare position peaked at $550K in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.